[go: up one dir, main page]

AU2002359126A1 - Benzodiazepine derivatives, preparation thereof and use thereof - Google Patents

Benzodiazepine derivatives, preparation thereof and use thereof

Info

Publication number
AU2002359126A1
AU2002359126A1 AU2002359126A AU2002359126A AU2002359126A1 AU 2002359126 A1 AU2002359126 A1 AU 2002359126A1 AU 2002359126 A AU2002359126 A AU 2002359126A AU 2002359126 A AU2002359126 A AU 2002359126A AU 2002359126 A1 AU2002359126 A1 AU 2002359126A1
Authority
AU
Australia
Prior art keywords
preparation
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359126A
Other versions
AU2002359126A8 (en
Inventor
Carmen Leung
Vijayaratnam Santhakumar
Miroslaw Tomaszewski
Simon Woo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2002359126A1 publication Critical patent/AU2002359126A1/en
Publication of AU2002359126A8 publication Critical patent/AU2002359126A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002359126A 2001-12-14 2002-12-11 Benzodiazepine derivatives, preparation thereof and use thereof Abandoned AU2002359126A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0104248A SE0104248D0 (en) 2001-12-14 2001-12-14 Method of treatment
SE0104248-0 2001-12-14
PCT/SE2002/002309 WO2003051275A2 (en) 2001-12-14 2002-12-11 Benzodiazepine derivatives, preparation thereof and use thereof

Publications (2)

Publication Number Publication Date
AU2002359126A1 true AU2002359126A1 (en) 2003-06-30
AU2002359126A8 AU2002359126A8 (en) 2003-06-30

Family

ID=20286350

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359126A Abandoned AU2002359126A1 (en) 2001-12-14 2002-12-11 Benzodiazepine derivatives, preparation thereof and use thereof

Country Status (3)

Country Link
AU (1) AU2002359126A1 (en)
SE (1) SE0104248D0 (en)
WO (1) WO2003051275A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2522024A1 (en) * 2003-04-15 2004-10-28 Merck & Co., Inc. Cgrp receptor antagonists
WO2005000807A2 (en) * 2003-06-26 2005-01-06 Merck & Co., Inc. Benzodiazepine cgrp receptor antagonists
DE602004026053D1 (en) * 2003-06-26 2010-04-29 Merck Sharp & Dohme
CN101124217A (en) * 2004-01-29 2008-02-13 默克公司 CGRP receptor antagonist
KR20130136010A (en) * 2005-04-13 2013-12-11 네우렉슨 인코포레이티드 Substituted indole compounds having nos inhibitory activity
JP5350219B2 (en) 2006-04-13 2013-11-27 ニューラクソン，インコーポレーテッド 1,5 and 3,6-substituted indole compounds having NOS inhibitory activity
WO2008079683A2 (en) 2006-12-20 2008-07-03 Abbott Laboratories N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
US8673909B2 (en) 2007-11-16 2014-03-18 Neuraxon, Inc. Indole compounds and methods for treating visceral pain
SMT201700035T1 (en) 2011-05-13 2017-03-08 Array Biopharma Inc Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
MX2013015058A (en) * 2011-06-24 2014-01-20 Amgen Inc Trpm8 antagonists and their use in treatments.
MY157429A (en) 2011-06-24 2016-06-15 Amgen Inc Trpm8 antagonists and their use in treatments
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
US9822118B2 (en) 2012-11-13 2017-11-21 Array Biopharma Inc. Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
WO2014078323A1 (en) 2012-11-13 2014-05-22 Array Biopharma Inc. N-pyrrolidinyl, n'-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
US9546156B2 (en) 2012-11-13 2017-01-17 Array Biopharma Inc. N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitors
WO2014078325A1 (en) 2012-11-13 2014-05-22 Array Biopharma Inc. N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
WO2014078417A1 (en) 2012-11-13 2014-05-22 Array Biopharma Inc. Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
US9981959B2 (en) 2012-11-13 2018-05-29 Array Biopharma Inc. Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
US9828360B2 (en) 2012-11-13 2017-11-28 Array Biopharma Inc. Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
WO2014078331A1 (en) 2012-11-13 2014-05-22 Array Biopharma Inc. N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
WO2014078372A1 (en) 2012-11-13 2014-05-22 Array Biopharma Inc. Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
WO2014078454A1 (en) 2012-11-13 2014-05-22 Array Biopharma Inc. Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
WO2015039334A1 (en) * 2013-09-22 2015-03-26 Merck Sharp & Dohme Corp. TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
HRP20191593T1 (en) 2014-05-15 2019-11-29 Array Biopharma Inc 1- (3S, 4R) -4- (3-FLUOROPHENYL) -1- (2-METHOXYLETHYL) PYROLIDIN-3-YL) -3- (4-METHYL-3- (2-METHYLPYRIMIDIN-5-YL) - 1-PHENYL-1H-PYRAZOL-5-YL) UREA AS A KINAS RACE INHIBITOR
UA115205C2 (en) * 2016-10-03 2017-09-25 Товариство З Додатковою Відповідальністю "Інтерхім" APPLICATION OF 7-BROMY-5- (O-CHLOROPHENYL) -3-PROPOXY-1,2-DIGIDRO-3H-1,4-BENZDIAZEPINE-2-ONE FOR BRAKING OF NEUROPATIC PAIN
UA119735C2 (en) 2018-12-20 2019-07-25 Анатолій Семенович Редер PHARMACEUTICAL COMPOUND, METHOD OF PREPARATION AND APPLICATION AS A MEDICINAL PRODUCT

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL96613A0 (en) * 1989-12-18 1991-09-16 Merck & Co Inc Pharmaceutical compositions containing benzodiazepine analogs
US5218114A (en) * 1991-04-10 1993-06-08 Merck & Co., Inc. Cholecystokinin antagonists
WO1993007131A1 (en) * 1991-10-10 1993-04-15 Merck Sharp & Dohme Limited Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
US5696110A (en) * 1991-10-24 1997-12-09 Merck, Sharp & Dohme, Ltd. Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
DE69204040T2 (en) * 1991-12-20 1996-03-28 Merck Sharp & Dohme 3-phenylureido-1,4-benzodiazepinones and their use as cholecystokinin or gastrin antagonists.
WO1993019052A1 (en) * 1992-03-24 1993-09-30 Merck Sharp & Dohme Limited 3-ureido substituted benzodiazepin-2-ones having cholecystokinin and/or gastrin antagonistic activity and their use in therapy
WO1994003447A1 (en) * 1992-07-29 1994-02-17 Merck Sharp & Dohme Limited Benzodiazepine derivatives
US5378838A (en) * 1993-01-13 1995-01-03 Merck & Co., Inc. Benzodiazepine cholecystokinin antagonists
JPH10504545A (en) * 1994-07-29 1998-05-06 藤沢薬品工業株式会社 Benzodiazepine derivatives

Also Published As

Publication number Publication date
WO2003051275A2 (en) 2003-06-26
SE0104248D0 (en) 2001-12-14
WO2003051275A3 (en) 2003-10-30
AU2002359126A8 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
AU2002359126A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU3958100A (en) New compounds, their preparation and use
AU3958200A (en) New compounds, their preparation and use
AU3957900A (en) New compounds, their preparation and use
AU2002359123A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2001248279A1 (en) New compounds, their preparation and use
IL159507A0 (en) Substituted dihydro 3-halo-1h pyrazole-5-carboxylates, their preparation and use
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
IL135451A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
AU2001234178A1 (en) Modified bdnf
AU2000254308A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
PL365342A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
AU5524400A (en) Novel 6-amino-uracil derivatives, preparation and use thereof
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application
AU2002332286A1 (en) Water-soluble phenylpyridazine derivatives and medicines containing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase